Year-over-year, this metric declined by 100.0%, from $379.00M to $0.00. This is a positive signal — lower values indicate better performance for this metric.
A significant impairment charge often signals poor past acquisition performance or a decline in the competitive position of a business unit.
This represents a non-cash charge taken when the carrying value of an intangible asset, such as goodwill or a brand name...
Occurs periodically across all industries; high frequency may indicate poor capital allocation discipline.
operating_impairment_of_intangible_assets_indefinitelive_3dfac8| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $379.00M | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | — | — | — | — | — | — | — | — | -100.0% | — | — | — |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | -100.0% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Pharmaceuticals | $379.00M | $0.00 | $0.00 | $0.00 | $0.00 |
| Total | $379.00M | $0.00 | $0.00 | $0.00 | $0.00 |